p53  	p53  	 NN	B-NP
gene  	gene  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
using  	using  	 VBG	O
RNA  	RNA  	 NNP	B-NP
interference  	interference  	 NN	I-NP
p53  	p53  	 NN	I-NP
gene 	gene 	 NN	I-NP
,  	,  	 ,	O
discovered  	discovered  	 VBD	O
almost  	almost  	 RB	O
35  	35  	 CD	O
years  	years  	 NNS	O
ago 	ago 	 RB	O
,  	,  	 ,	O
keeps  	keeps  	 VBZ	O
the  	the  	 DT	O
main  	main  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
cell  	cell  	 NN	O
cycle  	cycle  	 NN	O
control 	control 	 NN	O
,  	,  	 ,	O
apoptosis  	apoptosis  	 JJ	B-NP
pathways  	pathways  	 NN	I-NP
and  	and  	 CC	O
transcription.  	transcription.  	 CD	B-NP
p53  	p53  	 NN	O
gene  	gene  	 NN	O
is  	is  	 VBZ	O
found  	found  	 VBN	O
mutated  	mutated  	 VBN	O
in  	in  	 IN	O
more  	more  	 JJR	O
than  	than  	 IN	O
50 	50 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
human  	human  	 JJ	O
cancers  	cancers  	 NNS	O
in  	in  	 IN	O
different  	different  	 JJ	O
locations 	locations 	 NNS	O
.  	.  	 .	O
Many  	Many  	 JJ	O
structures  	structures  	 NNS	O
from  	from  	 IN	O
viral  	viral  	 JJ	O
to  	to  	 TO	O
non  	non  	 VB	O
viral  	viral  	 NNS	O
were  	were  	 VBD	O
designed  	designed  	 VBN	O
to  	to  	 TO	O
incorporate  	incorporate  	 VB	O
and  	and  	 CC	O
deliver  	deliver  	 VB	O
in  	in  	 IN	O
appropriate  	appropriate  	 JJ	O
conditions  	conditions  	 NNS	O
forms  	forms  	 NNS	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
gene  	gene  	 NN	I-NP
or  	or  	 CC	O
its  	its  	 PRP$	O
transcripts 	transcripts 	 NNS	O
,  	,  	 ,	O
systemically  	systemically  	 VBG	O
to  	to  	 TO	O
target  	target  	 VB	O
tumor  	tumor  	 NN	B-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
to  	to  	 TO	O
eliminate  	eliminate  	 VB	O
them  	them  	 PRP	O
through  	through  	 IN	O
apoptosis  	apoptosis  	 NN	B-NP
or  	or  	 CC	O
to  	to  	 TO	O
restore  	restore  	 VB	O
the  	the  	 DT	O
normal  	normal  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
suppressor  	suppressor  	 NN	I-NP
gene  	gene  	 NN	I-NP
role 	role 	 NN	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
delivery  	delivery  	 NN	B-NP
system  	system  	 NN	I-NP
presents  	presents  	 VBZ	O
advantages  	advantages  	 NNS	O
and  	and  	 CC	O
low  	low  	 JJ	O
performance  	performance  	 NN	O
in  	in  	 IN	O
relation  	relation  	 NN	O
to  	to  	 TO	O
immune  	immune  	 JJ	O
system  	system  	 NN	B-NP
recognition  	recognition  	 NN	I-NP
and  	and  	 CC	O
acceptance 	acceptance 	 NN	O
.  	.  	 .	O
One  	One  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
major  	major  	 JJ	O
discoveries  	discoveries  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
years 	years 	 NNS	O
,  	,  	 ,	O
silencing  	silencing  	 VBG	O
of  	of  	 IN	O
RNA 	RNA 	 NNP	B-NP
,  	,  	 ,	O
represents  	represents  	 VBZ	O
a  	a  	 DT	O
powerful  	powerful  	 JJ	O
tool  	tool  	 NN	O
for  	for  	 IN	O
inhibiting  	inhibiting  	 JJ	O
post  	post  	 NN	B-NP
transcriptional  	transcriptional  	 NN	I-NP
control  	control  	 NN	I-NP
of  	of  	 IN	I-NP
gene  	gene  	 NN	I-NP
expression 	expression 	 NN	I-NP
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
several  	several  	 JJ	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
RNA  	RNA  	 NNP	B-NP
silencing  	silencing  	 JJ	O
technology  	technology  	 NN	O
for  	for  	 IN	O
p53  	p53  	 NN	B-NP
transcripts  	transcripts  	 NNS	I-NP
together  	together  	 RB	O
with  	with  	 IN	O
other  	other  	 JJ	O
carriers  	carriers  	 NNS	O
or  	or  	 CC	O
transporters  	transporters  	 NN	B-NP
at  	at  	 IN	O
nano  	nano  	 JJ	B-NP
level  	level  	 NN	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
for  	for  	 IN	O
creating  	creating  	 VBG	O
new  	new  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
models 	models 	 NNS	I-NP
.  	.  	 .	O
RNA  	RNA  	 NNP	B-NP
interference  	interference  	 NN	I-NP
for  	for  	 IN	I-NP
p53  	p53  	 NN	I-NP
uses  	uses  	 VBZ	O
different  	different  	 JJ	O
double-stranded  	double-stranded  	 NN	B-NP
( 	( 	 -LRB-	O
ds 	ds 	 LS	B-NP
)  	)  	 -RRB-	O
molecules  	molecules  	 NNS	O
like  	like  	 IN	O
short  	short  	 JJ	O
interfering  	interfering  	 NNS	O
( 	( 	 -LRB-	O
si 	si 	 LS	B-NP
)  	)  	 -RRB-	O
RNA  	RNA  	 NNP	B-NP
and 	and 	 CC	O
,  	,  	 ,	O
despite  	despite  	 IN	O
the  	the  	 DT	O
difficulty  	difficulty  	 NN	O
of  	of  	 IN	O
introducing  	introducing  	 VBG	O
them  	them  	 PRP	O
into  	into  	 IN	O
mammalian  	mammalian  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
immune  	immune  	 JJ	O
system  	system  	 NN	B-NP
response 	response 	 NN	I-NP
,  	,  	 ,	O
it  	it  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
exploited  	exploited  	 VBN	O
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
